menu ☰
menu ˟

Interim PET scans predict relapse of non-bulky early-stage Hodgkin’s lymphoma

22 Dec 2015
ORLANDO, Fla. — Interim PET scans served as a biomarker for relapse in patients with non-bulky, stage I to stage II Hodgkin’s lymphoma who received ABVD chemotherapy, according to initial study findings presented at the ASH Annual Meeting and Exp...

Click here to view the full article which appeared in Hematology Oncology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.